Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Feb 25 | LYEL Lyell Immunopharma | Common Stock | Grant | Acquire A | No | No | 0 | 112,500 | 0.00 | 172,725 |
10 Feb 25 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 0.5535 | 56,250 | 31.13 k | 56,250 |
10 Feb 25 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 0.5535 | 450,000 | 249.08 k | 450,000 |
10 Jun 24 | TSVT 2seventy bio | Common Stock | Grant | Acquire A | No | No | 0 | 6,025 | 0.00 | 22,625 |
10 Jun 24 | TSVT 2seventy bio | Stock Options Common Stock | Grant | Acquire A | No | No | 3.93 | 12,050 | 47.36 k | 12,050 |
3 Jun 24 | CHRS Coherus BioSciences | Stock Option Common Stock | Grant | Acquire A | No | No | 1.76 | 112,000 | 197.12 k | 112,000 |
20 Mar 24 | TSVT 2seventy bio | Common Stock | Grant | Acquire A | No | No | 0 | 16,600 | 0.00 | 16,600 |
20 Mar 24 | TSVT 2seventy bio | Stock Options Common Stock | Grant | Acquire A | No | No | 4.54 | 33,400 | 151.64 k | 33,400 |